Zomedica Pharmaceuticals
Healthcare Services · Michigan, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
100 Phoenix Dr Ste 125, Ann Arbor, Michi...Phone Number
(734) 369-2555Website
www.zomedica.comRevenue
$28.4 MillionStock Symbol
ZOMIndustry
ZI Rank: 6
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
5
4
6
5
4
6
About Zomedica Pharmaceuticals
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2015. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.Explore more
Zomedica Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
RB
Senior Director, Development & Engineering
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zomedica Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Zomedica Pharmaceuticals recently announced quarterly report
Check out if Zomedica Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Zomedica Pharmaceuticals
Check if Zomedica Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Zomedica Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Zomedica Pharmaceuticals has new funding data
Zomedica Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Zomedica Pharmaceuticals launches new products
Recommended Actions
Find VP level buyers at Zomedica Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Zomedica Pharmaceuticals
Compare insights from companies similar to Zomedica Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Zomedica Pharmaceuticals is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Zomedica Pharmaceuticals is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Zomedica Pharmaceuticals.
Zomedica Pharmaceuticals financials insights
Gather financial insights about Zomedica Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Zomedica Pharmaceuticals Tech Stack
A closer look at the technologies used by Zomedica Pharmaceuticals
See more technologies
Most Recent Scoops
Earnings
Zomedica Pharmaceuticals has stated that share buybacks will not be considered until the company achieves cash flow positivity and GAAP profitability, which is expected in 2027, with management indicating it believes sufficient capital exists to reach cash flow breakeven and profitability.
Business Finance, Finance, Financial Operations
Partnership
Zomedica Pharmaceuticals has announced the continuation of its partnership with Boehringer Ingelheim, with the TRUFORMA program extending into the fall season in the United States, a similar program planned for Canada beginning in August, and exploration of comparable programs with Boehringer Ingelheim subsidiaries outside the United States.
Partnership
Pain Point
Zomedica Pharmaceuticals has reported that a competitor has added one of its diagnostic assays to their own platform and redirected existing users, representing a competitive challenge to the company's installed base, with a response currently in development aimed at recovering those customers.
CRM, Pain Point, Account Management, Customer Retention & Development
Project
Zomedica Pharmaceuticals is progressing with its PIMS integration project, currently live in pilot accounts connecting myZomedica to the largest market share PIMS provider in animal health with a second provider also under testing, targeting full integration across all products and major PIMS providers for small animal and equine by September 2026.
Proof of Concept (POC), Product Development
Partnership
Partnership
Zomedica Pharmaceuticals News & Media
Zomedica Corp. (ZOMDF) Discusses Five Pillars Framework for Clinical Value and Shareholder Returns in Veterinary Practice Transcript
Zomedica Corp. (ZOMDF) Discusses Five Pillars Framework for Clinical Value and Shareholder Returns in Veterinary Practice June 26, 2026 4:00 PM EDTCompany...Zomedica Corp. (ZOMDF) Shareholder/Analyst Call Prepared Remarks Transcript
Zomedica Corp. (ZOMDF) Shareholder/Analyst Call June 10, 2026 11:00 AM EDTCompany ParticipantsLarry Heaton - President, CEO & DirectorJeffrey...Zomedica Corp. (ZOMDF) Q1 2026 Earnings Call Transcript
Zomedica Corp. (ZOMDF) Q1 2026 Earnings Call May 29, 2026 4:00 PM EDTCompany ParticipantsLarry Heaton - President, CEO & DirectorAmy SchaefferTammy...Zomedica Corp. (ZOMDF) Discusses Manufacturing Strategy and Quality Operations for Veterinary Diagnostics and Therapeutics Transcript
Zomedica Corp. (ZOMDF) Discusses Manufacturing Strategy and Quality Operations for Veterinary Diagnostics and Therapeutics April 24, 2026 4:00 PM EDTCompany...
Read more news
Top Healthcare Services Companies
Frequently Asked Questions Regarding Zomedica Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of... Read More
